Macular Degeneration Clinical Trial
Official title:
A Phase II Randomized, Double-Masked, Study Comparing the Safety and Efficacy of ATG003 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (NV-AMD)
This is a Phase II randomized, double-masked study comparing the safety and efficacy of ATG003 (mecamylamine HCl) 1.0% and 0.3% ophthalmic solutions to placebo in patients with neovascular ("wet") age-related macular degeneration (NV-AMD).
| Status | Terminated |
| Enrollment | 343 |
| Est. completion date | September 2009 |
| Est. primary completion date | June 2009 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 50 Years and older |
| Eligibility |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Brazil | Hospital de Olhos de Araraquara | Araraquara | |
| Brazil | Centro Brasileiro de Ciências Visuais | Belo Horizonte | |
| Brazil | Instituto da Visão | Belo Horizonte | |
| Brazil | Centro Brasileiro de Cirurgia dos Olhos | Goiânia | |
| Brazil | Hospital de Clinicas de Porto Alegre | Porto Alegre | |
| Brazil | Hospital Universitário Clementino Fraga Filho | Rio de Janeiro | |
| Brazil | Clínica de Olhos Dr. Suel Abujamra | São Paulo | |
| Brazil | Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo | São Paulo | |
| Brazil | Hospital de Olhos de São Paulo | São Paulo | |
| Brazil | Hospital São Paulo - Setor de Pesquisa Clínica | São Paulo | |
| Czech Republic | University Hospital Brno, Department of Ophthalmology | Brno | |
| Czech Republic | Eye Clinic University Hospital | Hradec Kralove | |
| Czech Republic | Ophthalmology Nemocnice Litomysl | Litomyšl | |
| Czech Republic | University Hospital Olomouc, Department of Ophthalmology | Olomouc | |
| Czech Republic | Faculty Hospital Kralovske Vinohrady, Dept. of Ophthalmology | Prague | |
| Czech Republic | Cornea Lexum Praha | Praha | |
| Mexico | Cif Biotec | CP | |
| Mexico | Hospital Conde de Valenciana | CP | |
| Mexico | Fundación Hospital "Nuestra Sra de la Luz" I.A.P. | Delegación Cuauhtémoc | |
| Mexico | Asociación Para Evitar la Ceguera | Mexico City | |
| Mexico | Hospital General de México | Mexico City | |
| Mexico | Hospital San José Tec de Monterrey | Monterrey | |
| Poland | Klinika Chorób Oczu | Gdansk | |
| Poland | Oddzial Okulistyczny Okregowy Szpital Kolejowy | Katowice | |
| Poland | Klinika Okulistyczna | Lodz | |
| Poland | Oddzial Okulistyki, Samodzielny Publiczny Szpital Kliniczny Nr 1 Przemienienia Panskiego AM w Poznaniu | Poznan | |
| Poland | Katedra i Klinika Okulistyki, Samodzielny Publiczny Kliniczny Szpital Okulistyczny | Warsaw | |
| Poland | Katedra i Klinika Okulistyki, Akademia Medyczna we Wroclawiu | Wroclaw | |
| Russian Federation | Republican Ophthalmologic Hospital of MH of Republic of Tatarstan | Kazan | |
| Russian Federation | IRTC "Eye Microsurgery" n. a. S.N. Fyodorov | Moscow | |
| Russian Federation | Moscow Scientific Research Institute of Eye Diseases | Moscow | |
| Russian Federation | CJSC "Inter Yuna" | Rostov-on Don | |
| Russian Federation | City Consultative Diagnostic Centre # 1 (St. Petersburg) | St. Petersburg | |
| Russian Federation | IRTC "Eye Microsurgery" n. a. S.N. Fyodorov | St. Petersburg | |
| Russian Federation | Military Medical Academy n.a. S.M.Kirov of Ministry of Defence | St. Petersburg | |
| Russian Federation | St. Petersburg State Medical University n. a. Pavlov | St. Petersburg | |
| Ukraine | Kyiv City Centre of Eye Vascular and Endocrine Diseases of Organ of Vision | Kyiv | |
| Ukraine | Kyiv City Ophthalmologic Hospital | Kyiv | |
| Ukraine | Kyiv City Ophthalmologic Hospital "Eye Microsurgery Centre" | Kyiv | |
| Ukraine | V.P. Filatov Institute of Eye Diseases and Tissue Pathology of AMS of Ukraine | Odessa | |
| Ukraine | Zaporizhzhya Center of Vision Rehabilitation | Odessa | |
| Ukraine | S.I. Georgiyevsky Crimean State Medical University | Simferopol |
| Lead Sponsor | Collaborator |
|---|---|
| CoMentis |
Brazil, Czech Republic, Mexico, Poland, Russian Federation, Ukraine,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Proportion of Subjects Losing Fewer Than 15 ETDRS Letters of Visual Acuity at 48 Weeks Compared to Baseline. | Baseline to Week 48 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06262737 -
Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol
|
||
| Completed |
NCT02540954 -
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
|
Phase 3 | |
| Completed |
NCT00385333 -
Metabolic Mapping to Measure Retinal Metabolism
|
Phase 2 | |
| Completed |
NCT02510794 -
Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
|
Phase 2 | |
| Terminated |
NCT02228304 -
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
|
Phase 1/Phase 2 | |
| Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
| Completed |
NCT02181504 -
A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration
|
Phase 2 | |
| Recruiting |
NCT01521065 -
An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
|
Phase 2 | |
| Completed |
NCT01204541 -
A Single-Center Pilot Study to Assess Macular Function
|
N/A | |
| Completed |
NCT00769392 -
Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection
|
N/A | |
| Completed |
NCT00536016 -
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
|
Phase 1 | |
| Withdrawn |
NCT00538538 -
Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)
|
Phase 1 | |
| Completed |
NCT00533520 -
Evaluation of Dosing Interval of Higher Doses of Ranibizumab
|
Phase 4 | |
| Terminated |
NCT00403442 -
Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD
|
Phase 1 | |
| Recruiting |
NCT00157976 -
Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
|
Phase 3 | |
| Completed |
NCT00239928 -
Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration
|
Phase 2 | |
| Completed |
NCT00211458 -
Treatment of Age-Related Macular Degeneration With Anecortave Acetate
|
Phase 2 | |
| Completed |
NCT00242580 -
A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
|
Phase 3 | |
| Completed |
NCT00095433 -
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
|
Phase 3 | |
| Completed |
NCT00006202 -
Lutein for Age-Related Macular Degeneration
|
Phase 2 |